Last update 12 Mar 2026

VSA-006

Overview

Basic Info

Drug Type
siRNA
Synonyms
VSA 006, VSA006
Target
17β-HSD13
Action
inhibitors
Mechanism
17β-HSD13 inhibitors(17-beta-hydroxysteroid dehydrogenase 13 inhibitors)
Therapeutic Areas
Digestive System Disorders
Active Indication
Metabolic Dysfunction Associated Steatohepatitis
Inactive Indication-
Originator Organization
Visirna Biotechnology (Shanghai) Co., Ltd.
Active Organization
Visirna Biotechnology (Shanghai) Co., Ltd.Visirna Therapeutics HK Limited
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

1
Clinical Trials associated with VSA-006
NCT06322628
/ Active, not recruitingPhase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of VSA006 Injection in Chinese Adult Patients With Nonalcoholic Steatohepatitis (NASH)
100 Clinical Results associated with VSA-006
Login to view more data
100 Translational Medicine associated with VSA-006
Login to view more data
100 Patents (Medical) associated with VSA-006
Login to view more data
100 Deals associated with VSA-006
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metabolic Dysfunction Associated SteatohepatitisPhase 2
China
Visirna Biotechnology (Shanghai) Co., Ltd.
08 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free